Biofrontera第二季度每股收益$（0.57）错过$（0.42）估计，销售额903万美元，超过830万美元估计

Biofrontera (NASDAQ: BFRI) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.42) by 35.71 percent. This is a 1040 percent decrease over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $9.03 million which beat the analyst consensus estimate of $8.30 million by 8.80 percent. This is a 14.41 percent increase over sales of $7.89 million the same period last year.